-
Recombinant Mouse M-CSF: Applied Workflows
2026-08-17
Build more reproducible mouse macrophage, osteoclast, cancer, and fibrosis assays with a tag-free M-CSF workflow. This guide connects controlled macrophage differentiation to metabolic and inflammatory readouts inspired by the IGF2BP1–THBS1–TLR4 pulmonary fibrosis axis.
-
B-Cell Ether Lipids Shape Germinal Centers
2026-08-16
The reference study shows that B-cell-intrinsic PexRAP, encoded by Dhrs7b, supports ether phospholipid production, B-cell survival, germinal center development, and effective antibody maturation. Its combination of inducible genetic models, imaging mass spectrometry, immunization, and mechanistic cell analysis provides a framework for connecting lipid metabolism with humoral immunity.
-
Tyrothricin in Reliable Viability Assays
2026-08-15
Learn how Tyrothricin (SKU BA1054) can be integrated into viability, cytotoxicity, and infection-model workflows without conflating antimicrobial effects with mammalian cell injury. This scenario-based guide covers controls, membrane-disruption studies, storage, redox-related interpretation, and practical vendor selection.
-
Tamoxifen in PINK1–Iron Cancer Models
2026-08-14
Tamoxifen is more than a selective estrogen receptor modulator in conditional cancer models: it can determine when and how CreER-mediated gene knockout is interpreted. This article connects tamoxifen experimental design with PINK1-dependent mitochondrial iron biology while separating genetic effects from drug-induced confounding.
-
Cy3-UTP and the Spatial Logic of RNA Processing
2026-08-14
A mechanistic and translational perspective on how Cy3-UTP can help researchers test RNA localization, nuclear speckle organization, and co-transcriptional processing hypotheses inspired by new findings on Alu repeat-containing RNAs.
-
Relative vs Fractional Viability in Cancer Drug Studies
2026-08-13
Hannah R. Schwartz’s 2022 dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer drug response. Its central finding is that drug-induced growth inhibition and cell death usually occur together, but in different proportions and with distinct timing, providing a stronger framework for interpreting in vitro pharmacology.
-
EdU Flow Cytometry Assay Kits (Cy3) for Prostate Cancer
2026-08-13
Translate BaP exposure studies into quantitative S-phase, tumor-cell, and immune-cell readouts with a denaturation-free click-chemistry workflow. The Cy3 assay supports multiplexed cell cycle analysis, genotoxicity testing, and pharmacodynamic experiments while preserving antigenicity for marker-based gating.
-
SP600125 JNK Inhibitor: Applied Workflows
2026-08-12
SP600125 enables time-resolved interrogation of JNK-dependent phosphorylation, apoptosis, and inflammatory signaling. This practical guide connects its established c-Jun and cytokine use cases with assay strategies inspired by recent trigeminal ganglion research, while clearly separating validated evidence from exploratory applications.
-
Recombinant Mouse M-CSF: Assay Design Guide
2026-08-12
Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF) can do more than expand macrophages: it can define the cellular baseline for mechanistic studies. This guide connects PM2021 biology with macrophage metabolism and fibrosis assay design while separating differentiation effects from disease-specific signaling.
-
Tamoxifen Workflows for CreER and Cancer Research
2026-08-11
Explore practical Tamoxifen workflows for temporally controlled CreER-mediated gene knockout, breast cancer research, and signaling assays. This guide also translates a SERM antimalarial study into hypothesis-driven assay design while emphasizing solubility control, appropriate comparators, and reproducible troubleshooting.
-
Deferasirox, Mitochondrial ROS, and Myeloid Maturation
2026-08-11
This 2024 short report shows that deferasirox has differentiation-stage-specific effects on mitochondrial reactive oxygen species, NF-κB-related transcription, and myeloid maturation. By combining murine and human models with hypoxia experiments and single-cell transcriptomics, the study provides a mechanistic framework for understanding both hematologic improvement and possible neutrophil-related toxicity.
-
γH2AX DNA Damage Detection Kit for DSB Assays
2026-08-10
Turn radiation, nanoparticle, and genotoxicity experiments into spatially resolved DNA double-strand break measurements with a red γ-H2AX signal and blue nuclear counterstain. This workflow shows how to optimize staining, quantify foci, and connect early DNA damage with apoptosis and repair outcomes.
-
Cy3-UTP: Reading RNA in Condensate Biology
2026-08-09
Cy3-UTP enables fluorescent RNA production for imaging, detection, and RNA-protein interaction studies. This article explains how to use Cy3-labeled transcripts to distinguish RNA localization from mechanistic evidence in phase-separated viral replication-organelle models.
-
Tricine-SDS-PAGE Gel Preparation Kit Guide
2026-08-08
The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit is intended for resolving low-molecular-weight proteins and peptides that are difficult to separate with conventional Tris-SDS-PAGE. It is suitable for research workflows using denaturing or non-denaturing electrophoresis, but it is not intended for diagnostic, clinical, or medical use.
-
Lysis Buffer for Rapid Mouse Genotyping Workflows
2026-08-07
Build faster, more consistent mouse genotyping workflows with a lysis buffer designed for tail, toe, and ear tissue digestion. This guide connects practical DNA-release steps with experimental planning inspired by a six-gene colorectal cancer study, while clearly separating validated product use from exploratory applications.